Tumour Microenvironment Modulation to Overcome Checkpoint Resistance: Where the Preclinical Rationale Holds. TMTJ [Internet]. 2026 Apr. 21 [cited 2026 Nov. 5];5(2):28-36. Available from: https://inkwise.org/index.php/TMTJ/article/view/119